Zydus Cadila gets tentative approval from USFDA for cancer drug
Shares of Cadila Healthcare, the listed entity of the group closed at Rs 531.35 per scrip on BSE, down 0.10 percent from its previous close.
Shares of Cadila Healthcare, the listed entity of the group closed at Rs 531.35 per scrip on BSE, down 0.10 percent from its previous close. https://ift.tt/37Pa2xf August 17, 2021 at 01:22AM
Shares of Cadila Healthcare, the listed entity of the group closed at Rs 531.35 per scrip on BSE, down 0.10 percent from its previous close. https://ift.tt/37Pa2xf August 17, 2021 at 01:22AM
Comments
Post a Comment